Viewing Study NCT06927661


Ignite Creation Date: 2025-12-24 @ 12:03 PM
Ignite Modification Date: 2025-12-27 @ 10:08 PM
Study NCT ID: NCT06927661
Status: RECRUITING
Last Update Posted: 2025-06-04
First Post: 2025-04-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: ENSAND 2.0 Evaluation in Nigeria
Sponsor: RTI International
Organization:

Study Overview

Official Title: Evaluation of the Global Alliance for Improved Nutrition (GAIN) the Enhancing Access to Safe and Nutritious Diets (ENSAND) 2.0 Project in Nigeria
Status: RECRUITING
Status Verified Date: 2025-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The Enhancing Access to Safe and Nutritious Diets 2.0 (ENSAND) (2024-2026) project is designed to address the low per capita consumption of vegetables and variety of vegetable consumption in northern Nigeria by working with smallholder farmers to increase production and promoting healthier diets through greater vegetable consumption among farmers and their neighbors. The objective of this evaluation is to assess the effectiveness of GAIN's ENSAND program for increasing the quantity and variety of vegetables consumed by smallholder farmer households participating in the program and neighbor households paired with the farmers. This evaluation will use a quasi-experimental design to assess the impact of GAIN's ENSAND programs on the quantity and diversity of vegetables consumed by smallholder farmers and their neighbors. The evaluation will be guided by the RE-AIM (reach, effectiveness, adoption, implementation, maintenance) framework. RE-AIM is a framework that is useful for evaluating the program impact of multifaceted and multilevel interventions.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: